The National Cancer Institute (NCI) is offering the Method to Extend Research in Time (MERIT) Award, specifically the R37 grant, to provide extended support for Early Stage Investigators (ESIs). This grant is for the purpose of offering eligible researchers up to seven years of funding, delivered in two segments, to foster flexibility, creativity, and innovation in their work. The NCI aims to give ESIs ample time to successfully launch and establish their careers before requiring them to submit renewal applications. This initiative helps solidify their research foundation, promoting long-term success and impactful contributions within the cancer research field.
Opportunity ID: 334005
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-138 |
| Funding Opportunity Title: | Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 04, 2021 |
| Last Updated Date: | Jun 04, 2021 |
| Original Closing Date for Applications: | Dec 01, 2024 |
| Current Closing Date for Applications: | Dec 01, 2024 |
| Archive Date: | Jan 06, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts State governments Special district governments Small businesses City or township governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI’s ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments: |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-138.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334005 Full Announcement-PAR-21-138 -> PAR-21-138-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00271836 | Jan 31, 2022 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00267556 | Jun 07, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278705 | Jun 07, 2021 | Jan 24, 2025 | View |
Package 1
Mandatory forms
334005 RR_SF424_5_0-5.0.pdf
334005 PHS398_CoverPageSupplement_5_0-5.0.pdf
334005 RR_OtherProjectInfo_1_4-1.4.pdf
334005 PerformanceSite_4_0-4.0.pdf
334005 RR_KeyPersonExpanded_4_0-4.0.pdf
334005 PHS398_ResearchPlan_4_0-4.0.pdf
334005 RR_Budget10_3_0-3.0.pdf
Optional forms
334005 RR_SubawardBudget10_30_3_0-3.0.pdf
334005 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Package 2
Mandatory forms
334005 RR_SF424_2_0-2.0.pdf
334005 PHS398_CoverPageSupplement_5_0-5.0.pdf
334005 RR_OtherProjectInfo_1_4-1.4.pdf
334005 PerformanceSite_2_0-2.0.pdf
334005 RR_KeyPersonExpanded_2_0-2.0.pdf
334005 PHS398_ResearchPlan_4_0-4.0.pdf
334005 RR_Budget10_1_4-1.4.pdf
Optional forms
334005 RR_SubawardBudget10_30_1_4-1.4.pdf
334005 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Package 3
Mandatory forms
334005 RR_SF424_5_0-5.0.pdf
334005 PHS398_CoverPageSupplement_5_0-5.0.pdf
334005 RR_OtherProjectInfo_1_4-1.4.pdf
334005 PerformanceSite_4_0-4.0.pdf
334005 RR_KeyPersonExpanded_4_0-4.0.pdf
334005 PHS398_ResearchPlan_5_0-5.0.pdf
334005 RR_Budget10_3_0-3.0.pdf
Optional forms
334005 RR_SubawardBudget10_30_3_0-3.0.pdf
334005 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
